1. Home
  2. MNOV vs HGBL Comparison

MNOV vs HGBL Comparison

Compare MNOV & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • HGBL
  • Stock Information
  • Founded
  • MNOV 2000
  • HGBL 1937
  • Country
  • MNOV United States
  • HGBL United States
  • Employees
  • MNOV N/A
  • HGBL N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • HGBL Business Services
  • Sector
  • MNOV Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • MNOV Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • MNOV 68.2M
  • HGBL 74.8M
  • IPO Year
  • MNOV 2005
  • HGBL N/A
  • Fundamental
  • Price
  • MNOV $1.35
  • HGBL $2.19
  • Analyst Decision
  • MNOV Strong Buy
  • HGBL Strong Buy
  • Analyst Count
  • MNOV 2
  • HGBL 1
  • Target Price
  • MNOV $7.00
  • HGBL $4.00
  • AVG Volume (30 Days)
  • MNOV 48.4K
  • HGBL 24.6K
  • Earning Date
  • MNOV 08-07-2025
  • HGBL 08-07-2025
  • Dividend Yield
  • MNOV N/A
  • HGBL N/A
  • EPS Growth
  • MNOV N/A
  • HGBL N/A
  • EPS
  • MNOV N/A
  • HGBL 0.12
  • Revenue
  • MNOV N/A
  • HGBL $46,659,000.00
  • Revenue This Year
  • MNOV N/A
  • HGBL $12.65
  • Revenue Next Year
  • MNOV N/A
  • HGBL $5.68
  • P/E Ratio
  • MNOV N/A
  • HGBL $18.02
  • Revenue Growth
  • MNOV N/A
  • HGBL N/A
  • 52 Week Low
  • MNOV $1.12
  • HGBL $1.52
  • 52 Week High
  • MNOV $2.55
  • HGBL $2.43
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 54.24
  • HGBL 51.59
  • Support Level
  • MNOV $1.31
  • HGBL $2.11
  • Resistance Level
  • MNOV $1.50
  • HGBL $2.20
  • Average True Range (ATR)
  • MNOV 0.06
  • HGBL 0.07
  • MACD
  • MNOV 0.02
  • HGBL -0.01
  • Stochastic Oscillator
  • MNOV 48.28
  • HGBL 42.11

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: